| Author | Vasconcellos, L. | |
| Author | Silva, S. V. | |
| Author | Costa, L. V. | |
| Author | Villas-boas, Maria Helena Simões | |
| Author | Brandão, Marcelo Luiz Lima | |
| Access date | 2023-11-09T14:16:21Z | |
| Available date | 2023-11-09T14:16:21Z | |
| Document date | 2023 | |
| Citation | VASCONCELLOS, L. et al. Molecular characterization of Pseudomonas aeruginosa strains isolated from pharmaceutical industry facility by eric-pcr and MLST. In: CONGRESSO BRASILEIRO DE MICROBIOLOGIA, 32., 2023, Foz do Iguaçu: SBM, 2023. 1 p. | en_US |
| URI | https://www.arca.fiocruz.br/handle/icict/61152 | |
| Language | por | en_US |
| Publisher | Instituto Nacional de Controle de Qualidade em Saúde | en_US |
| Rights | open access | en_US |
| Subject in Portuguese | Farmacoresistência Bacteriana | en_US |
| Subject in Portuguese | Infecções por Pseudomonas aeruginosa | en_US |
| Subject in Portuguese | Resistência a multidrogas | en_US |
| Subject in Portuguese | Pseudomonas aeruginosa | en_US |
| Title | Molecular characterization of Pseudomonas aeruginosa strains isolated from pharmaceutical industry facility by eric-pcr and MLST | en_US |
| Type | Papers presented at events | en_US |
| Abstract | Pseudomonas aeruginosa is a saprophytic microorganism that causes human infections, in particular respiratory tract infections. It’s a pathogen that can survive and form biofilms on inert materials surfaces (Zhang et al., 2017). Multidrug resistance of this pathogen was reported, and the World Health Organization has classified it as a critical priority due to its resistance to carbapenems (WHO, 2017). In the pharmaceutical industry, the isolation of P. aeruginosa can mean contamination during the stages of the production chain (Anvisa, 2017). In this scenario, molecular characterization techniques, such as the Enterobacterial Repetitive Intergenic Consensus Polymerase Chain Reaction (ERIC-PCR) (Versalovic et al.,1991) and the Multilocus Sequence Typing (MLST), allow an assessment of the genetic diversity and clonal profile of these strains (Maiden et al., 1998, 2013), helping the evaluation of deviation and risk analysis, making decisions regarding immunobiological products. | en_US |
| Affilliation | Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos de Controle Microbiológico. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Nacional de Controle de Qualidade em Saúde. Laboratório de Microbiologia de Alimentos e Saneantes. Rio de Janeiro, RJ, Brasil. | en_US |
| Affilliation | Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos de Controle Microbiológico. Rio de Janeiro, RJ, Brasil. | |
| Affilliation | Fundação Oswaldo Cruz. Instituto Nacional de Controle de Qualidade em Saúde. Laboratório de Microbiologia de Alimentos e Saneantes. Rio de Janeiro, RJ, Brasil. | |
| Affilliation | Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos de Controle Microbiológico. Rio de Janeiro, RJ, Brasil. | |
| Subject | Drug resistence | en_US |
| Subject | Pseudomonas aeruginosa | en_US |
